Dario Kivelevitch
Overview
Explore the profile of Dario Kivelevitch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
961
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cunningham C, Limmer A, Kivelevitch D
Dermatol Online J
. 2024 Dec;
30(4).
PMID: 39644482
No abstract available.
2.
Nadir U, Lauck K, Kivelevitch D
Arch Dermatol Res
. 2024 Nov;
316(10):751.
PMID: 39503879
No abstract available.
3.
Lauck K, Limmer A, Harris P, Kivelevitch D
J Am Acad Dermatol
. 2024 Mar;
91(1):163-166.
PMID: 38552905
No abstract available.
4.
Malick H, Lauck K, Kivelevitch D
JAMA Dermatol
. 2023 Dec;
160(1):117.
PMID: 38055233
No abstract available.
5.
Menter A, Krueger G, Paek S, Kivelevitch D, Adamopoulos I, Langley R
Dermatol Ther (Heidelb)
. 2021 Jan;
11(2):385-400.
PMID: 33512665
Psoriasis is an immune-mediated inflammatory skin disease associated with numerous inflammatory comorbidities, including increased cardiovascular risk. The interleukin (IL)-23/IL-17 axis plays a central role in the immunopathogenesis of psoriasis and...
6.
Azhar A, Zaayman M, Silfvast-Kaiser A, Kivelevitch D, Menter A, Paek S
Dermatol Ther
. 2020 Nov;
34(1):e14486.
PMID: 33135231
Ixekizumab is a humanized monoclonal antibody that exhibits its immunomodulatory effects by binding to interleukin 17A (IL-17A), a proinflammatory cytokine. It was approved for the treatment of plaque psoriasis by...
7.
Elmets C, Korman N, Prater E, Wong E, Rupani R, Kivelevitch D, et al.
J Am Acad Dermatol
. 2020 Aug;
84(2):432-470.
PMID: 32738429
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care...
8.
Menter A, Gelfand J, Connor C, Armstrong A, Cordoro K, Davis D, et al.
J Am Acad Dermatol
. 2020 Mar;
82(6):1445-1486.
PMID: 32119894
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 2% of the world's population. In this guideline, we focus the discussion on systemic, nonbiologic medications for...
9.
Menter A, Cordoro K, Davis D, Kroshinsky D, Paller A, Armstrong A, et al.
J Am Acad Dermatol
. 2019 Nov;
82(1):161-201.
PMID: 31703821
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management...
10.
Elmets C, Lim H, Stoff B, Connor C, Cordoro K, Lebwohl M, et al.
J Am Acad Dermatol
. 2019 Jul;
81(3):775-804.
PMID: 31351884
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 3.2% of the world's population. In this section of the guidelines of care for psoriasis, we will...